skip to content
   

PRESS RELEASES

THE SAGE GROUP Releases New Estimates for the United States Prevalence, Incidence and Costs of Chronic Venous Disese (CVD), Varicose Veins and Venous Ulcers. December 20, 2016.

THE SAGE GROUP Releases New Estimates for the United States Prevalence and Incidence of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI). October 25, 2016.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP LLC Comments on the Economic Burden of the Disease. September 14, 2016. 

THE SAGE GROUP Announces that Mary L. Yost, President, Will Present Several Lectures on Peripheral Artery Disease (PAD), Critical Limb Ischemia (CLI) and Amputation at the 17th Annual NEW CARDIOVASCULAR HORIZONS (NCVH) Meeting. May 23, 2016.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Lecture at the NEW CARDIOVASCULAR HORIZONS (NCVH) Second Annual “Understanding the Business of Peripheral Interventions” Session. May 13, 2016. 

September is Peripheral Artery Disease (PAD) Awareness Month; THE SAGE GROUP Highlights PAD Costs and Consequences. September 9, 2015.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Lecture at the NEW CARDIOVASCULAR HORIZONS (NCVH) Inaugural Economic Session “Understanding the Business of Peripheral Interventions.” May 12, 2015.

According to THE SAGE GROUP, 4-5 million People in Mexico Suffer from Peripheral Artery Disease. November 4, 2014.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Peripheral Arterial Disease (PAD) at the 2014 National Congress of Angiology and Vascular Surgery in Mexico. October 15,2014. 

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease. September 8, 2014.

THE SAGE GROUP Estimates the Economic Cost of Critical Limb Ischemia Amputations at $25 Billion. August 15, 2014.

THE SAGE GROUP LLC Announces Publication of an Article Titled “Cost-Benefit Analysis of Amputation in the Era of the Affordable Care Act. Is it Fiscally Responsible to Perform Primary Amputation as Treatment?” in the May Issue of Endovascular Today.
June 2, 2014.

In Recognition of National Diabetes Month, THE SAGE GROUP LLC Highlights the Interrelationships Between Peripheral Artery Disease (PAD) and Diabetes, Diabetic Foot Ulcers (DFU) and Amputation. November 12, 2013.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Disease. September 5, 2013.

According to THE SAGE GROUP Peripheral Artery Disease Amputations are Costly for the Economy, the Hospital and for the Patient. August 19, 2013.

THE SAGE GROUP Reports that Approximately 14 Million People in South America Suffer from Peripheral Artery Disease. July 9, 2013.

THE SAGE GROUP LLC Announces that Mary L. Yost, President, will Lecture on Socioeconomics of Amputation at the Save A Leg Save A Life Foundation Annual National Conference. April 8, 2013.

September 17, 2012
 
 
 
 
 

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Economic Burden of the Disease. September 8, 2011.
 
 
 

THE SAGE GROUP Reports that in 2010 Approximately 3 Million People in Western Europe Suffer from Critical Limb Ischemia.
 December 15, 2010
 
 
 

According to THE SAGE GROUP, Almost 3 Million People in India Suffer From Critical Limb Ischemia Caused by Atherosclerotic Peripheral Arterial Disease. November 12, 2009.

THE SAGE GROUP Supports the "STOP P.A.D." Petition Drive to Expand Medicare Coverage to Test patients for peripheral Arterial Disease. September 15, 2009.

THE SAGE GROUP Reports that in 2007 Approximately 2.8 million people in Western Europe Suffered from Critical Limb Ischemia. October 20, 2008.

THE SAGE GROUP Reports that in 2007 Between 4 and 8.4 Million Europeans Suffered from the Symptoms of Intermittent Claudication. February 28, 2008. 

THE SAGE GROUP Finds a Significant Number of New Pharmaceuticals in Clinical Trials for Treatment of Peripheral Arterial Disease. February 13, 2008. 

THE SAGE GROUP Reports that in 2006 Approximately 2 Million People in the United States Suffered from Critical Limb Ischemia. April 17, 2007.

THE SAGE GROUP Commends the Launch of the National Peripheral Arterial Disease Awareness Campaign "Stay in Circulation: Take Steps to Learn About P.A.D." September 20, 2006.

THE SAGE GROUP Reports that the Acute Limb Ischemia (ALI) Market is Approximately $800 Million to $1.2 Billion. September 21, 2005.

Peripheral Arterial Disease (PAD)-Related Amputations Cost an Estimated $10 Billion, According to THE SAGE GROUP. September 9, 2004.

Peripheral Arterial Disease Represents a Significant and Rapidly Growing Market Opportunity for Interventional Therapies, Particularly Endovascular Technologies. August 25, 2004.

Peripheral Arterial Disease Seen as a Major New Market for Drug and Interventional Therapies, According to an Analysis Published by THE SAGE GROUP. May 21, 2003.

THE SAGE GROUP Research:

Approximately 1.5 million South Americans have critical limb ischemia.

South America Diabetes, Peripheral Artery Disease and Critical Limb Ischemia.

An estimated 3.3 million people in Western Europe have critical limb ischemia.

 Critical Limb Ischemia, Volume II Western Europe Epidemiology

In 2015 between 2.0 and 3.4 million U.S. citizens suffered from critical limb ischemia.

Critical Limb Ischemia
Volume I United States Epidemiology
 2016 Supplement

 

Approximately 3.8 million people in India are currently afflicted with atherosclerotic critical limb ischemia.

India
Peripheral Arterial Disease, Thromboangiitis Obliterans & Critical Limb Ischemia
 Epidemiology and Markets

 

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development